We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADP icon
76
Automatic Data Processing
ADP
$109B
$309K 0.07%
3,360
+650
+24% +$57.4K
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.14T
$309K 0.07%
2,137
+70
+3% +$10K
INTC icon
78
Intel
INTC
$492B
$308K 0.07%
9,390
+525
+6% +$16.4K
SWH
79
DELISTED
Stanley Black & Decker, Inc.
SWH
$308K 0.07%
2,650
– –
SNY icon
80
Sanofi
SNY
$104B
$307K 0.07%
7,325
– –
TEVA icon
81
Teva Pharmaceuticals
TEVA
$42.1B
$306K 0.07%
6,100
– –
PCAR icon
82
PACCAR
PCAR
$69.1B
$303K 0.07%
8,775
– –
UPS icon
83
United Parcel Service
UPS
$89.1B
$291K 0.07%
2,700
– –
VOD icon
84
Vodafone
VOD
$36.4B
$262K 0.06%
8,484
-434
-5% -$14.1K
SYY icon
85
Sysco
SYY
$40.1B
$259K 0.06%
5,100
– –
WBA
86
DELISTED
Walgreens Boots Alliance
WBA
$250K 0.06%
3,011
– –
MON
87
DELISTED
Monsanto Co
MON
$228K 0.05%
2,200
– –
HD icon
88
Home Depot
HD
$350B
$224K 0.05%
1,750
+150
+9% +$19.8K
AWR icon
89
American States Water
AWR
$3.43B
$223K 0.05%
5,080
– –
MITT.PRB
90
TPG Mortgage Investment Trust 8.00% Series B Preferred Stock
MITT.PRB
$93.3M
$196K 0.05%
8,000
+1,400
+21% +$33.4K
WEC icon
91
WEC Energy
WEC
$34.6B
$196K 0.05%
3,000
– –
MET icon
92
MetLife
MET
$61.7B
$180K 0.04%
5,052
– –
NSC icon
93
Norfolk Southern
NSC
$75B
$175K 0.04%
2,050
+350
+21% +$29.7K
COP icon
94
ConocoPhillips
COP
$148B
$174K 0.04%
4,000
– –
TGT icon
95
Target
TGT
$69B
$166K 0.04%
2,375
– –
AMZN icon
96
Amazon
AMZN
$3T
$161K 0.04%
+4,500
New +$152K
ED icon
97
Consolidated Edison
ED
$39.3B
$161K 0.04%
2,000
– –
SO icon
98
Southern Company
SO
$105B
$161K 0.04%
3,000
– –
BA icon
99
Boeing
BA
$184B
$150K 0.03%
1,155
+235
+26% +$30.6K
DLR icon
100
Digital Realty Trust
DLR
$70.8B
$147K 0.03%
1,350
– –
2 3
4
5 6

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.